Stonepine Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-216,307
| Closed | -$2.38M | – | 31 |
|
|
2017
Q2 | $2.38M | Sell |
216,307
-1,446,974
| -87% | -$15.9M | 1.28% | 20 |
|
|
2017
Q1 | $16.3M | Buy |
1,663,281
+414,081
| +33% | +$4.06M | 9.19% | 4 |
|
|
2016
Q4 | $13.5M | Buy |
+1,249,200
| New | +$13.5M | 8.04% | 4 |
|
|
2016
Q3 | – | Sell |
-1,082,532
| Closed | -$14.1M | – | 24 |
|
|
2016
Q2 | $14.1M | Sell |
1,082,532
-966,106
| -47% | -$12.6M | 14.5% | 1 |
|
|
2016
Q1 | $22.5M | Buy |
2,048,638
+873,064
| +74% | +$9.6M | 26.58% | 1 |
|
|
2015
Q4 | $10.8M | Buy |
+1,175,574
| New | +$10.8M | 12.67% | 3 |
|